Engineers Gate Manager LP Deciphera Pharmaceuticals, Inc. Transaction History

Engineers Gate Manager LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$13.58 - $17.36 $317,459 - $405,824	23,377 New	23,377 $367,000
Q3 2023 Nov 14, 2023	BUY	$12.46 - $15.48 $334,638 - $415,746	26,857 New	26,857 $341,000
Q1 2023 May 15, 2023	BUY	$14.26 - $22.1 $187,119 - $289,996	13,122 Added 119.76%	24,079 $372,000
Q4 2022 Feb 14, 2023	SELL	$14.85 - $19.04 $174,086 - $223,205	-11,723 Reduced 51.69%	10,957 $179,000
Q3 2022 Nov 14, 2022	BUY	$12.38 - $20.23 $280,778 - $458,816	22,680 New	22,680 $420,000

293K

500

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

Stay updated on Engineers Gate Manager LP with notifications on news.